Despite the limited number of patients and the few neuropsychological data reported in the literature, the overall data suggest the need for a specific assessment for ADHD, ASD and cognitive development in patients with epilepsy related to SLC6A1 pathogenic variants. Here, SLC6A1 is linked to attention deficit-hyperactivity disorder.